- FDA Places Clinical Hold on Pacritinib for Myelofibrosis
- The US Food and Drug Administration (FDA) had placed a full clinical hold on pacritinib (CTI BioPharma), an investigational agent for the treatment of myelofibrosis.
- FDA Places Full Clinical Hold on Myelofibrosis Drug Pacritinib
- The FDA has placed a full clinical hold on myelofibrosis trials exploring the JAK2/FLT3 inhibitor pacritinib, following reports of patient deaths related to intracranial hemorrhage, cardiac failure and cardiac arrest in the phase 3 PERSIST-2 trial.
- Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Global API Manufacturers
- Post-Polycythemia Vera Myelofibrosis PPV-MF - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across ...
- Myelofibrosis – Pipeline Review, H2 2015 by ReportBazzar.
- This report provides comprehensive information on the therapeutic development for Myelofibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and ...
Myelofibrosis is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Myelofibrosis books and related discussion.
Suggested News Resources
Great care has been taken to prepare the information on this page. Elements of the content come from factual and lexical knowledge databases, realmagick.com library and third-party sources. We appreciate your suggestions and comments on further improvements of the site.
Related searchesentropy of mixing liquids
roger de montgomery
censorship in the united kingdom
folly examples include